This handbook provides an overview of the law applicable to asylum, border management and immigration in relation to European Union (EU) law and the European Convention on Human Rights (ECHR). It looks at the situation of those foreigners whom the EU usually refers to as third-country nationals. Thi...s handbook is designed to assist legal practitioners as well as non-governmental organisations (NGOs) and other bodies that are not specialised in the field of asylum, borders and immigration law and that may be confronted with legal qüstions relating to these subjects.
For versions in other European languages check also http://fra.europa.eu/de/publication/2013/handbuch-zu-den-europarechtlichen-grundlagen-im-bereich-asyl-grenzen-und-migration
more
Ciudad de México, México - 26 al 28 de mayo del 2014
DEMOGRAPHIC AND HEALTH SURVEYS DHS WORKING PAPERS 2015 No. 117
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...ркулеза, в том числе новым и применяющимся по новым показаниям.
more
Dans le cadre du projet Tracmed, une étude sur les outils législatifs et juridiques à disposition des ordres des pharmaciens dans la lutte contre les médicaments falsifiés a été réalisée en juillet 2015. Cette étude porte sur le Bénin, le Burkina Faso, la Guinée et le Mali.
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...ARVs that are recommended by the World Health Organization (WHO) as well as new ARVs that have either recently obtained regulatory approval or are in phase III clinical trials.
more
Componente del Juego de herramientas para la prevención: “Cómo reconocer las deficiencias de nacimiento”
This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds would be eligible for pharmacological treatment of hype...rtension according to the WHO guidelines, all of whom had SBP/DBP at least 160/100 mmHg.
more
Now entering its sixth year, the conflict in Syria continues to take a drastic toll on the lives of the Syrian people and to drive an unprecedented humanitarian and protection crisis: some 13.5 million people are now in need of humanitarian assistance and protection, including 6 million children. Ha...lf of the country’s pre-crisis population has been forced from their homes, with around one third of the remaining population now displaced within Syria and over 4.8 seeking refuge in neighbouring countries and beyond.
more
The framework responds to the demand from Member States and partners for guidance on how the health sector and its operational basis in health systems can systematically and effectively address the challenges increasingly presented by climate variability and change. This framework has been designed ...in light of the increasing evidence of climate change and its associated health risks (1); global, regional and national policy mandates to protect population health (2); and a rapidly emerging body of practical experience in building health resilience to climate change (3).
more